CSL Behring

IL - BradleyBiotechnology10 H-1B visas (FY2023)

Focus: CSL Behring is a global biopharmaceutical company headquartered in Bradley, Illinois, specializing in biologics for rare diseases, neurology, infectious diseases, nephrology, and cardiovascular conditions. The company maintains a substantial pipeline with 147 active job openings and demonstrates strong operational scale.

Rare Diseases Neurology Infectious Diseases Nephrology

Profile data last refreshed 7h ago · AI intelligence enriched 2w ago

Open Jobs

About CSL Behring

AI assessmentNot Hiring

No open roles listed right now. Follow CSL Behring to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

2/9 — Limited

Company HealthSolid

Pipeline

Early-stage

50 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

ANDEMBRY

Hereditary Angioedema, Idiopathic Pulmonary Fibrosis, COVID-19

Launch

Factor XIIa antagonist monoclonal antibody approved for HAE; first-in-class mechanism with multi-indication potential drives near-term commercial momentum.

Products & Portfolio (1)

Help build intelligence for CSL Behring

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Extensive pipeline of 160+ programs across hemophilia, immunodeficiency, hereditary angioedema, and emerging modalities including gene therapy and monoclonal antibodies
Strong hiring momentum with 147 active roles, particularly in Commercial (36), R&D (16), and Regulatory Affairs (13), signaling growth investment
Perfect H1B sponsorship record (10 approvals, 0 denials in 2023) indicates established visa infrastructure and commitment to global talent acquisition
Portfolio spans rare disease genetics, coagulation disorders, and immunotherapy—high-complexity science with meaningful patient impact

Pipeline & Clinical Trials

Hizentra

Chronic Inflammatory Demyelinating Polyneuropathy

N/A

Clinical Trials (1)

NCT04672733Hizentra® in Inflammatory Neuropathies - pHeNIx Study

N/A

HEMGENIX

Hemophilia B

N/A

Clinical Trials (1)

NCT06008938An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B

N/A

Vitamin D and calcium

Hemophilia A

N/A

Clinical Trials (1)

NCT01090206Correlation Between Vitamin D Status and Bone Mineral Density in Patients With Hemophilia

N/A

HOME LINK

Chronic Inflammatory Demyelinating Polyneuropathy

N/A

Clinical Trials (1)

NCT03779828Evaluating the Effectiveness of Telemonitoring System in the Management of Patients With CIDP

N/A

Observatory of Patients With Haemophilia B Treated by IdElvion®

Haemophilia B

N/A

Clinical Trials (1)

NCT05086575Observatory of Patients With Haemophilia B Treated by IdElvion®

N/A

FVIII Concentrates

Severe Hemophilia A

N/A

Intravenous Immunoglobulin

Chronic Inflammatory Demyelinating Polyneuropathy

N/A

Clinical Trials (1)

NCT02414490IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements

N/A

Health Related Quality of Life of Youth and Young Adults With Hemophilia A

Hemophilia A

N/A

Clinical Trials (1)

NCT01034904Health Related Quality of Life of Youth and Young Adults With Hemophilia A

N/A

Berinert®

Includes: Hereditary Angioedema

N/A

Clinical Trials (1)

NCT01108848Patient Registry Study of Berinert® in Normal Clinical Practice

N/A

CSL312

Hereditary Angioedema (HAE)

N/A

Clinical Trials (1)

NCT07159464Post Study Access of CSL312 (Garadacimab) for Pediatric Participants With Hereditary Angioedema Who Have Completed the CSL312_3003 Study

N/A

Respreeza® Self-administration and Learning Program (AmAREtTI Study)

Alpha-1 Antitrypsin Deficiency

N/A

Clinical Trials (1)

NCT04262284Respreeza® Self-administration and Learning Program (AmAREtTI Study)

N/A

Rabies Vaccine

Rabies

N/A

Clinical Trials (1)

NCT01063140Rabies Immune Plasma Booster Study

N/A

Blood collection

Ataxia Telangiectasia

N/A

Clinical Trials (1)

NCT02345135Susceptibility to Infections in Ataxia Telangiectasia

N/A

FCH

Congenital Fibrinogen Deficiency

N/A

Clinical Trials (1)

NCT02427217An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency

N/A

SQ IVIG

Infections After Lung Transplant

N/A

Clinical Trials (1)

NCT01361178Immunoglobulin Levels and Occurrence of Infections After Lung Transplantation and Impact of IgG Replacement

N/A

Data collection on interventions performs as per medical routine

Anemia

N/A

Clinical Trials (1)

NCT06878105Patient Blood Management Implementation in CEE Study

N/A

Joint Health Study

Hemophilia B

N/A

Clinical Trials (1)

NCT03358836Joint Health Study

N/A

Immune Globulin Subcutaneous

Chronic Inflammatory Demyelinating Polyneuropathy

N/A

Clinical Trials (1)

NCT02465359Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

N/A

Australian and New Zealand Massive Transfusion Registry

Massive Transfusion

N/A

Fibrogammin P

Hemophilia

N/A

Clinical Trials (1)

NCT00640289Clinical Trial of Factor XIII (FXIII) Concentrate

N/A

Genetic Sequencing

Alpha-1 Antitrypsin Deficiency

N/A

Clinical Trials (1)

NCT02810327Alpha-1 Carrier Genomics Study

N/A

AAV5-hFIX

Hemophilia B

N/A

Clinical Trials (1)

NCT05360706Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B

N/A

CSL830

Various

N/A

Clinical Trials (1)

NCT03177005Expanded Access for Hereditary Angioedema (HAE)

N/A

VWF/FVIII concentrates

Severe Hemophilia A

N/A

No intervention

Hereditary Angioedemas

N/A

Clinical Trials (1)

NCT07001280A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)

N/A

The German Patient Blood Management Network

Clinical Safety of a PBM Program

N/A

VWF/FVIII products

Von Willebrand Disease

N/A

Clinical Trials (1)

NCT00557908The Von Willebrand Disease (VWD) International Prophylaxis Study

N/A

Precision Medicine in Cardiovascular Surgery Associated Acute Kidney Injury

Acute Kidney Injury

N/A

Clinical Trials (1)

NCT06471621Precision Medicine in Cardiovascular Surgery Associated Acute Kidney Injury

N/A

Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013

Hemophilia

N/A

subcutaneous immunoglobulin

Hypogammaglobulinemia

N/A

Clinical Trials (1)

NCT03401268Subcutaneous Ig in Allogeneic Stem Cell Transplant Recipients

N/A

Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients

Surgery

N/A

Von Willebrand Disease in the Netherlands

Von Willebrand Disease

N/A

Clinical Trials (1)

NCT03521583Von Willebrand Disease in the Netherlands

N/A

Privigen

Systemic Sclerosis

N/A

Clinical Trials (1)

NCT01785056IVIG Treatment in Systemic Sclerosis

N/A

Pulmonary rehabilitation

Chronic Obstructive Pulmonary Disease

N/A

Clinical Trials (1)

NCT02915614Effects of Pulmonary Rehabilitation on Skeletal Muscle in COPD Patients

N/A

gammaglobulin

Common Variable Immunodeficiency

N/A

Clinical Trials (1)

NCT00661401Specific IgG Antibody in Patients With Primary Antibody Deficiencies Treated With Subcutaneous Immunoglobulin

N/A

Chronic active AMR group

Antibody-mediated Rejection in Kidney Transplant

N/A

Clinical Trials (1)

NCT05452317Assess Burden of Disease Among Kidney Transplant Recipients With Chronic Active Antibody Mediated Rejection

N/A

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Hematologic Disorder

N/A

Additional blood sampling at the same time and in addition of samplings already done for the patient's standard of care.

Liver Cirrhosis

N/A

Clinical Trials (1)

NCT06050993Effects of Platelet Mimicking Nanoparticles in Patients With Cirrhosis

N/A

Kcentra®

Hemorrhage

N/A

Clinical Trials (1)

NCT02319460An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding

N/A

mgt of bleeding concerns/complications of oral anticoagulants

Blood Coagulation

N/A

ATHN 8: Previously Untreated Patients (PUPs) Matter Study

Hemophilia

N/A

Beriplex® P/N

Coagulation Protein Disorders

N/A

Clinical Trials (1)

NCT01053169Observational Study of Prophylaxis and Treatment of Acute Perioperative Bleeding With Beriplex® P/N (Probe Study)